UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 1.120

Sortiert nach

The atherogenic dyslipidemia ratio [log(TG)/HDL-C] is associated with residual vascular risk, beta-cell function loss and microangiopathy in type 2 diabetes females

Lipids in health and disease, 2012-10, Vol.11 (1), p.132-132, Article 132

2012

Volltextzugriff (PDF)

Electronic health record acceptance by physicians: Testing an integrated theoretical model

Journal of biomedical informatics, 2014-04, Vol.48, p.17-27

2014

Volltextzugriff (PDF)

1,25-Dihydroxyvitamin D to PTH(1-84) Ratios Strongly Predict Cardiovascular Death in Heart Failure

PloS one, 2015-08, Vol.10 (8), p.e0135427

2015

Volltextzugriff (PDF)

Increased CRP: An extended biomarker of microvascular risk in men with type 2 diabetes

Journal of diabetes and its complications, 2019-11, Vol.33 (11), p.107413-107413, Article 107413

2019

Volltextzugriff (PDF)

Additional Prognostic Value of 2D Right Ventricular Speckle-Tracking Strain for Prediction of Survival in Heart Failure and Reduced Ejection Fraction: A Comparative Study With Cardiac Magnetic Resonance

JACC. Cardiovascular imaging, 2019-12, Vol.12 (12), p.2373-2385

2019

Volltextzugriff (PDF)

Non-HDL-cholesterol as valid surrogate to apolipoprotein B100 measurement in diabetes: Discriminant Ratio and unbiased equivalence

Cardiovascular diabetology, 2011-02, Vol.10 (1), p.20-20

2011

Volltextzugriff (PDF)

Validation of SURE, a Four-Item Clinical Checklist for Detecting Decisional Conflict in Patients

Medical decision making, 2014-01, Vol.34 (1), p.54-62

2014

Volltextzugriff (PDF)

log(TG)/HDL-C is related to both residual cardiometabolic risk and β-cell function loss in type 2 diabetes males

Cardiovascular diabetology, 2010-12, Vol.9 (1), p.88-88

2010

Volltextzugriff (PDF)

The antihyperlipidemic effect of a combined supplement of standardized dry extracts of amla ( Emblica officinalis ), walnut ( Juglans regia ), olive ( Olea europaea ) and red yeast rice ( Monascus purpureus ) powder: Reduction in circulatory low-density lipoprotein-cholesterol (LDL-C) and remnant cholesterol (RC) levels in patients with hypercholesterolemia

Frontiers in pharmacology, 2023-11, Vol.14, p.1280234-1280234

2023

Volltextzugriff (PDF)

Gender Difference in Internet Use and Internet Problems among Quebec High School Students

Canadian journal of psychiatry, 2016-10, Vol.61 (10), p.663-668

2016

Volltextzugriff (PDF)

The mixed benefit of low lipoprotein(a) in type 2 diabetes

Lipids in health and disease, 2017-09, Vol.16 (1), p.171-171, Article 171

2017

Volltextzugriff (PDF)

Increased plasma myostatin in heart failure

European journal of heart failure, 2011-07, Vol.13 (7), p.734-736

2011

Volltextzugriff (PDF)

Increased soluble ST2 is a stronger predictor of long-term cardiovascular death than natriuretic peptides in heart failure patients with reduced ejection fraction

International journal of cardiology, 2014-03, Vol.172 (1), p.e250-e252

2014

Volltextzugriff (PDF)

Lipoprotein(a) Levels Are Twice as High in Left-Handed T2DM Patients

Diabetes (New York, N.Y.), 2018-07, Vol.67 (Supplement_1)

2018

Volltextzugriff (PDF)

Beyond abuse and neglect: validation of the childhood interpersonal trauma inventory in a community sample of adults

Frontiers in psychiatry, 2024-02, Vol.15, p.1358475-1358475

2024

Volltextzugriff (PDF)

Are you SURE? Assessing patient decisional conflict with a 4-item screening test

Canadian family physician, 2010-08, Vol.56 (8), p.e308-e314

2010

Volltextzugriff (PDF)

What my body looks like and what my body can do: A self-perception explanation of excessive exercise in young adults with anorexia and/or bulimia

Frontiers in psychology, 2022-10, Vol.13, p.916294-916294

2022

Volltextzugriff (PDF)

Lipid and cardiometabolic features of T2DM patients achieving stricter LDL-C and non-HDL-C targets in accordance with ESC/EAS 2019 guidelines

Acta Cardiologica, 2021-07, Vol.76 (4), p.375-383

2021

Volltextzugriff (PDF)

Prognostic Value of Myocardial Viability by Delayed-Enhanced Magnetic Resonance in Patients With Coronary Artery Disease and Low Ejection Fraction: Impact of Revascularization Therapy

Journal of the American College of Cardiology, 2012-02, Vol.59 (9), p.825-835

2012

Volltextzugriff (PDF)

Head to head comparison of intact and C-terminal fibroblast growth factor 23 in heart failure patients with reduced ejection fraction

International journal of cardiology, 2017-12, Vol.248, p.270-273

2017

Volltextzugriff (PDF)

Prognostic Impact of Hypertrabeculation and Noncompaction Phenotype in Dilated Cardiomyopathy: A CMR Study

JACC. Cardiovascular imaging, 2015-08, Vol.8 (8), p.934-946

2015

Volltextzugriff (PDF)

C-terminal FGF23 is a strong predictor of survival in systolic heart failure

Peptides (New York, N.Y. : 1980), 2012-10, Vol.37 (2), p.258-262

2012

Volltextzugriff (PDF)

[HDL‐C/apoA‐I]: A multivessel cardiometabolic risk marker in women with T2DM

Diabetes/metabolism research and reviews, 2018-01, Vol.34 (1), p.n/a

2018

Volltextzugriff (PDF)

Incremental value of intact fibroblast growth factor 23 to natriuretic peptides for long-term risk estimation of heart failure patients

Clinical biochemistry, 2018-11, Vol.61, p.47-49

2018

Volltextzugriff (PDF)

Prognostic Value of Pulmonary Transit Time by Cardiac Magnetic Resonance on Mortality and Heart Failure Hospitalization in Patients With Advanced Heart Failure and Reduced Ejection Fraction

Circulation. Cardiovascular imaging, 2021-01, Vol.14 (1), p.e011680-e011680

2021

Volltextzugriff (PDF)

1 – 25 von 1.120

Suche als RSS-Feed

Aktive Filter

ThemaAnimals

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(950)
Mit Volltextzugriff
(1.036)

Publikationsform

4 weitere anzeigen...

Weniger anzeigen...

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

The atherogenic dyslipidemia ratio [log(TG)/HDL-C] is associated with residual vascular risk, beta-cell function loss and microangiopathy in type 2 diabetes females

Electronic health record acceptance by physicians: Testing an integrated theoretical model

1,25-Dihydroxyvitamin D to PTH(1-84) Ratios Strongly Predict Cardiovascular Death in Heart Failure

Increased CRP: An extended biomarker of microvascular risk in men with type 2 diabetes

Additional Prognostic Value of 2D Right Ventricular Speckle-Tracking Strain for Prediction of Survival in Heart Failure and Reduced Ejection Fraction: A Comparative Study With Cardiac Magnetic Resonance

Non-HDL-cholesterol as valid surrogate to apolipoprotein B100 measurement in diabetes: Discriminant Ratio and unbiased equivalence

Validation of SURE, a Four-Item Clinical Checklist for Detecting Decisional Conflict in Patients

log(TG)/HDL-C is related to both residual cardiometabolic risk and β-cell function loss in type 2 diabetes males

Gender Difference in Internet Use and Internet Problems among Quebec High School Students

The mixed benefit of low lipoprotein(a) in type 2 diabetes

Increased plasma myostatin in heart failure

Increased soluble ST2 is a stronger predictor of long-term cardiovascular death than natriuretic peptides in heart failure patients with reduced ejection fraction

Lipoprotein(a) Levels Are Twice as High in Left-Handed T2DM Patients

Beyond abuse and neglect: validation of the childhood interpersonal trauma inventory in a community sample of adults

Are you SURE? Assessing patient decisional conflict with a 4-item screening test

What my body looks like and what my body can do: A self-perception explanation of excessive exercise in young adults with anorexia and/or bulimia

Lipid and cardiometabolic features of T2DM patients achieving stricter LDL-C and non-HDL-C targets in accordance with ESC/EAS 2019 guidelines

Prognostic Value of Myocardial Viability by Delayed-Enhanced Magnetic Resonance in Patients With Coronary Artery Disease and Low Ejection Fraction: Impact of Revascularization Therapy

Head to head comparison of intact and C-terminal fibroblast growth factor 23 in heart failure patients with reduced ejection fraction

Prognostic Impact of Hypertrabeculation and Noncompaction Phenotype in Dilated Cardiomyopathy: A CMR Study

C-terminal FGF23 is a strong predictor of survival in systolic heart failure

[HDL‐C/apoA‐I]: A multivessel cardiometabolic risk marker in women with T2DM

Incremental value of intact fibroblast growth factor 23 to natriuretic peptides for long-term risk estimation of heart failure patients

Prognostic Value of Pulmonary Transit Time by Cardiac Magnetic Resonance on Mortality and Heart Failure Hospitalization in Patients With Advanced Heart Failure and Reduced Ejection Fraction

Aktive Filter

Suchergebnisse filtern